Valuation: Makers Laboratories Limited

Market Cap 1.07B 11.09M 9.9M 9.24M 8.39M 15.79M 15.94M 111M 43.38M 546M 41.63M 40.73M 1.75B P/E 2025
10.2x
P/E 2026 33.9x
Enterprise Value 1.02B 10.5M 9.38M 8.75M 7.95M 14.96M 15.1M 105M 41.09M 517M 39.44M 38.58M 1.66B EV / Sales 2025
0.67x
EV / Sales 2026 0.53x
Free-Float
32.46%
Yield 2025 *
-
Yield 2026 -

Last Transcript: Makers Laboratories Limited

1 day-1.62%
1 week-1.86%
Current month-1.86%
1 month-4.66%
3 months+21.25%
6 months+22.15%
Current year+54.04%
1 week 175.05
Extreme 175.05
187
1 month 171
Extreme 171
197.8
Current year 112.1
Extreme 112.1
236.55
1 year 109
Extreme 109
236.55
3 years 105
Extreme 105
236.55
5 years 94
Extreme 94
236.55
10 years 23.2
Extreme 23.2
344.8
Manager TitleAgeSince
Director of Finance/CFO 59 29/10/2017
Compliance Officer - 22/05/2024
Sales & Marketing 54 01/08/2017
Director TitleAgeSince
Director/Board Member 51 10/08/2011
Director/Board Member 52 28/01/2018
Chairman 77 27/03/2019
Change 5-day change 1-year change 3-year change Capi.($)
-1.62%-1.86%+30.00%+64.78% 11.28M
-1.61%+1.08%+38.64%+106.93% 1,060B
-0.76%-3.12%+35.78%+62.70% 623B
+0.39%+4.14%+17.00%+83.77% 480B
-0.29%-2.02%+62.52%+37.06% 352B
-2.03%+1.03%+22.25%+42.16% 345B
-1.92%-1.87%+11.94%+33.20% 274B
-2.36%-3.16%-6.95%+8.68% 249B
-1.37%-3.34%+37.86%+52.33% 223B
+0.17%-1.31%+25.96%+96.82% 182B
Average -1.53%-0.46%+27.50%+58.84% 378.8B
Weighted average by Cap. -1.39%+0.04%+30.57%+68.82%

Financials

2025 2026
Net sales 1.21B 12.47M 11.13M 10.39M 9.43M 17.75M 17.93M 125M 48.77M 614M 46.81M 45.8M 1.97B 1.41B 14.55M 12.99M 12.12M 11.01M 20.71M 20.91M 145M 56.9M 716M 54.61M 53.43M 2.3B
Net income 74.91M 773K 691K 644K 585K 1.1M 1.11M 7.74M 3.03M 38.06M 2.9M 2.84M 122M 23.51M 243K 217K 202K 184K 346K 349K 2.43M 950K 11.95M 912K 892K 38.43M
Net Debt 48.19M 498K 444K 415K 377K 709K 715K 4.98M 1.95M 24.49M 1.87M 1.83M 78.76M -56.5M -583K -521K -486K -441K -831K -839K -5.83M -2.28M -28.71M -2.19M -2.14M -92.33M
Projected Income Statement - Annual - Makers Laboratories Limited
Logo Makers Laboratories Limited
Makers Laboratories Limited is an integrated pharmaceutical company manufacturing and marketing around 200 formulations. The Company's segments include Pharmaceutical and Chemical Manufacturing. It has one manufacturing unit in India manufacturing formulations for the Indian market. Its product portfolio covers a range of general health therapeutic segments. Its formulation brands are Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimesulide), Coffwin (Anti-Cough range) and Exylin (Amoxycillin range). It also offers a range of diabetic and hypertensive drugs, including Voglibose, Gli-me range (Glimepiride + Metformin +Pioglitazone), and Hypernorm range (Telmisartan). Its product categories include Inspira - Retail Packs and Experia - Bulk Packs. Its Inspira - Retail Packs include anthelmintics, anti-biotics, anti-emetics and anti-nauseants. Its Experia - Bulk Packs include betamethasone 0.5 mg tablets, chloramphenicol capsules 250 mg and diclofenac 50 mg tablets.
Employees
114
Date Price Change Volume
08/10/26 ₹182.00 -1.62% 1,171
07/10/26 ₹185.00 +1.09% 58
06/10/26 ₹183.00 +1.47% 431
05/10/26 ₹180.35 -0.74% 302
01/10/26 ₹181.70 -2.02% 1,157
  1. Stock Market
  2. Stocks
  3. MAKERSL Stock